Gruppi di Lavoro - 19° Congresso Nazionale ICAR, Roma 19-21...

I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure...

I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections I Gruppi di Lavoro di ICAR 2027: Virology, reservoir, and cure strategies; Immunology, inflammation, and vaccines; Epidemiology: HIV cascade, testing strategies, and linkage to care; New issues in antiretroviral therapy and long-acting agents; Ageing, cancer, and non-communicable diseases; Hepatitis, MASLD, and other Liver Diseases; Pre-exposure Prophylaxis and other prevention strategies; Sexually Transmitted Infections

Gruppi di Lavoro
Virology, reservoir and cure strategies

Francesca Ceccherini Silberstein, Roma; Sandro Mattioli, Bologna; Stefano Rusconi, Legnano MI; Francesco Saladini, Siena; Maria Santoro, Roma; Ombretta Turriziani, Roma
Chairs e Referenti: Fabrizio Maggi, Roma; Maurizio Zazzi, Siena

Immunology, inflammation and vaccines

Chiara Agrati, Roma; Benedetto Maurizio Celesia, Modica; Gabriella d’Ettorre, Roma; Marco Falaguasta, Padova; Miriam Lichtner, Roma; Camilla Tincati, Milano
Chairs e Referenti: Andrea Cossarizza, Modena; Giulia Carla Marchetti, Milano

Epidemiology: HIV cascade, testing strategies and linkage to care

Maria Luisa Cosmaro, Milano; Paolo Meli, Bergamo; Annalisa Saracino, Bari; Francesco Vairo, Roma
Chairs e Referenti: Massimo Farinella, Roma; Giordano Madeddu, Sassari

New issues in antiretroviral therapy and long-acting agents

Alberto Borghetti, Pisa; Tommaso Clemente, Milano; Andrea De Vito, Sassari; Roberta Gagliardini, Roma; Andrea Giacomelli, Milano; Simone Lanini, Udine; Sergio Lo Caputo, Foggia; Cristina Mussini, Modena; Annalisa Perziano, Torino; Vincenzo Spagnuolo, Milano
Chairs e Referenti: Annamaria Cattelan, Padova; Franco Maggiolo, Fabro TR

Ageing, cancer and non-communicable diseases

Andrea Calcagno, Novara; Antonella Cingolani, Roma; Paola Cinque, Milano; Vincenzo Esposito, Napoli; Emanuele Focà, Brescia; Cristina Gervasoni, Milano; Giovanni Guaraldi, Modena; Lucia Taramasso, Genova
Chairs e Referenti: Paolo Bonfanti, Monza; Nicoletta Frattini, Milano

Hepatitis, MASLD and other Liver Diseases

Massimo Puoti, Milano; Valentina Svicher, Roma; Elisabetta Teti, Roma
Chairs e Referenti: Nicola Coppola, Napoli; Loredana Sarmati, Roma

Pre-exposure Prophylaxis and other prevention strategies

Salvatore Cecere, Bologna; Leonardo del Negro, Roma; Francesco Fusco, Napoli; Marianna Menozzi, Modena; Davide Moschese, Milano; Angelo Roberto Raccagni, Milano
Chairs e Referenti: Massimo Cernuschi, Milano; Valentina Mazzotta, Roma

Sexually Transmitted Infections

Enrico Caruso, Milano; Rozenn Esvan, Roma; Alessandra Latini, Roma; Antonio Muscatello, Milano; Marco Ridolfi, Roma; Roberto Rossotti, Verona; Pietro Vinti, Milano
Chairs e Referenti: Anna Maria Geretti, Roma; Silvia Nozza, Milano

Enti promotori

Promosso da
SIMIT - Società Italiana di Malattie Infettive e Tropicali

e da

INMI, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani IRCCS

ISS, Istituto Superiore di Sanità

AMCLI, Associazione Microbiologi Clinici Italiani

SIICA, Società Italiana di Immunologia, Immunologia Clinica e Allergologia

SIMaST, Società Interdisciplinare per lo Studio delle Malattie Sessualmente Trasmissibili

SITA, Società Italiana per la Terapia Antinfettiva Antibatterica Antivirale Antifungina

SIV-ISV, Società Italiana di Virologia - Italian Society for Virology

ANLAIDS, Associazione Nazionale per la Lotta contro l’AIDS ETS

ARCIGAY, Associazione LGBTQIA+ Italiana APS

ARCOBALENO Aids ODV

ASA, Associazione Solidarietà AIDS-ODV

C.I.C.A., Coordinamento Italiano delle case alloggio per persone con HIV/AIDS ETS

EpaC, Associazione EpaC ETS

LILA, Lega Italiana per la Lotta contro l’AIDS OdV

Mario Mieli, Circolo Cultura Omosessuale Mario Mieli APS

Milano Checkpoint, Associazione Milano Checkpoint ETS

NADIR, Associazione Nadir ETS

NPS Italia, Network Persone Sieropositive APS

PLUS, Rete persone LGBT+ sieropositive APS

icona